May 12, 2025
All resources
Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
Filter by
May 06, 2025
May 06, 2025
Canadian drug access pathway
The process for Canadians to access new medicines is extremely complex and involves several different federal, provincial, and territorial agencies. It takes two years following approval (736 days) for Canadian patients to get access to a drug in the public plan, whereas those in the private plan get access to a drug in less than one year (226 days).
July 29, 2024
October 06, 2023
October 06, 2023
Two years is too long – Understanding Canada’s drug access pathway
Canadians wait two years for access to new medicines through our public drug plans. That’s a full year longer than patients in most other peer countries. Two years can feel like a lifetime for a patient waiting for access to life-saving medicines or treatments.
November 07, 2022
June 03, 2021
June 03, 2021
Industry fact check
Learn facts and myths about the price of medicines, healthcare cost drivers and the economic contribution of industry.
May 18, 2021
February 04, 2021
February 04, 2021
Healthcare spending in Canada
Patented medicines represent 6.6 per cent of healthcare spending in Canada.
July 24, 2020
July 24, 2020
June 30, 2020
June 30, 2020
How would a single-payer publicly funded national pharmacare program affect the quality of access to medicines for Canadian patients?
Canada’s dual-payer pharmacare program works for most Canadians. But gaps need to be filled to ensure all Canadians have access to the medicines they need, regardless of income, age, sex or postal code.
March 02, 2019
